Safety of cetirizine ophthalmic solution 0.24% for the treatment of allergic conjunctivitis in adult and pediatric subjects

Lignende værker

• Phase III trials examining the efficacy of cetirizine ophthalmic solution 0.24% compared to vehicle for the treatment of allergic conjunctivitis in the conjunctival allergen challenge model
  af: Meier, Edward J, et al.
  Udgivet: (2018)
• Update and clinical utility of alcaftadine ophthalmic solution 0.25% in the treatment of allergic conjunctivitis
  af: Chigbu, DeGaulle I, et al.
  Udgivet: (2015)
• Evaluation of the Effect of Latanoprostene Bunod Ophthalmic Solution, 0.024% in Lowering Intraocular Pressure over 24 h in Healthy Japanese Subjects
  af: Araie, Makoto, et al.
  Udgivet: (2015)
• Treatment of allergic conjunctivitis with bepotastine besilate ophthalmic solution 1.5%
  af: Bergmann, Mark T, et al.
  Udgivet: (2014)
• Comparative study of the ocular efficacy and safety of diclofenac sodium (0.1%) ophthalmic solution with that of ketorolac tromethamine (0.5%) ophthalmic solution in patients with acute seasonal allergic conjunctivitis
  af: Dehar, Navdeep, et al.
  Udgivet: (2012)